Advertisement
Co Presented By
Co Presented By

Piramal deletes 'sure' from ovaluation kit, tells Delhi HC won't use in other drugs

The pharma company gave the undertaking, on affidavit, to a bench of justice Indermeet Kaur who was hearing a trademark infringement case filed against Piramal by Assure Life Science Pvt Ltd.

Advertisement
FP Archives|Jun 01, 2015, 19:41:07 IST

New Delhi: Piramal Healthcare Ltd has agreed in Delhi High Court to stop using the word 'sure' as a brand name for its ovulation kit product or for any other drug manufactured by it.[caption id="attachment_5904" align="alignleft" width="380"]Piramal Group chairman Ajay Piramal. Reuters Piramal Group chairman Ajay Piramal. Reuters[/caption]The pharma company gave the undertaking, on affidavit, to a bench of justice Indermeet Kaur who was hearing a trademark infringement case filed against Piramal by Assure Life Science Pvt Ltd.Piramal gave the affidavit pursuant to its submission before the court on 19 May that the word 'sure' shall not be used as a trade name in the manufacturing and sale of any of its products.It had also told the court that its "infringing material under the trade name 'I-Sure' which was in the market will be phased out within an outer limit of three months by withdrawing the products from the retailers to whom the product had been sold".On 25 May, Piramal filed the affidavit in relation to its submission of 19 May and thereafter, the court disposed of Assure Life Science' plea.

Handpicked stories, in your inbox
Global stories. Indian perspective. Zero noise.
No Spam. Unsubscribe Any Time.
First Published:Jun 01, 2015, 19:41:07 IST
Advertisement
Advertisement
Trending Stories

Tesla sells more cars but makes less money: Why Musk’s AI pivot is squeezing profits

Tesla’s record Q2 deliveries failed to translate into higher profits as price cuts, falling regulatory-credit revenue and Elon Musk’s aggressive AI spending squeezed margins and pushed the EV maker into negative free cash flow
5 min read
Advertisement
Advertisement
Up Next